Aroa Biosurgery Ltd (ARX)

Sydney
Currency in AUD
Disclaimer
0.67
-0.01(-1.47%)
Closed
Day's Range
0.660.69
52 wk Range
0.631.25
Bid/Ask
0.67 / 0.69
Prev. Close
0.68
Open
0.68
Day's Range
0.66-0.69
52 wk Range
0.63-1.25
Volume
187,151
Average Volume (3m)
310,440
1-Year Change
-39.09%
Shares Outstanding
343,441,402
Fair Value
Unlock
Dividends Payment Streak
Unlock
Analysts
Technical
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
1.44
Upside +114.93%
How do you feel today about ARX?
Vote to see community's results!
or

Aroa Biosurgery Ltd Company Profile

Aroa Biosurgery Limited, a regenerative medicine company, engages in the developing, manufacturing, and sells medical devices for wound and tissue repair using extracellular matrix (ECM) technology in the United States and internationally. Its products include Endoform Natural and Endoform Antimicrobia Restorative Bioscaffold for treating acute and chronic wounds; Myriad Matrix, an engineered ECM for soft tissue repair, reinforcement, and complex wounds; Myriad Morcells, a morcellized (powdered) format of Myriad Matrix for soft tissue repair and complex wounds; and Reinforced Bioscaffolds, a surgical product for use in ventral hernia repair and abdominal wall reconstruction. The company was incorporated in 2007 and is headquartered in Auckland, New Zealand.